Precision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
4 years agoPrecision Medicine in Oncology: A Comparative Evaluation of SMDCs and ADCs
Targeted therapy - a treatment targeting proteins responsible for cancer growth - is one of the latest developments in precision oncology. The variable response of cancer treatments highlights the need to develop therapies that can target the specific profile of...
4 years ago
Disease Models and Target Validation: An Interview with Professor Gavin Woodhall
In a recent interview with Proventa, Professor Gavin Woodhall, research scientist and Head of Neuroscience at Aston University, discussed the challenges of modelling human disease and the impact of alternative models on target validation. Professor Woodhall has an extensive academic...
4 years agoDisease Models and Target Validation: An Interview with Professor Gavin Woodhall
In a recent interview with Proventa, Professor Gavin Woodhall, research scientist and Head of Neuroscience at Aston University, discussed the challenges of modelling human disease and the impact of alternative models on target validation. Professor Woodhall has an extensive academic...
4 years ago
An Evaluation of Data Capture and Visualization in Clinical Research
Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...
4 years agoAn Evaluation of Data Capture and Visualization in Clinical Research
Data capture and visualization are the key components of clinical trial data analysis. However, with the explosion of COVID-19 around the world, data collection became difficult with poor patient recruitment and a reduction in face-to-face clinics. Advancements in telehealth have...
4 years ago
Challenges of Modelling Human Disease – Optimising Target Validation
The complexity of the human body presents a challenge when choosing a model that is translatable and can also be manipulated for target validation. In addition to the popular animal models, recent innovations in computational biology has seen significant advancements...
4 years agoChallenges of Modelling Human Disease – Optimising Target Validation
The complexity of the human body presents a challenge when choosing a model that is translatable and can also be manipulated for target validation. In addition to the popular animal models, recent innovations in computational biology has seen significant advancements...
4 years ago
The Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
4 years agoThe Clinical Challenges of Rare Disease Research: An Interview with Dr. Evangeline Wassmer
In a recent interview with Dr. Evangeline Wassmer, Paediatric neurology consultant at Birmingham Children’s Hospital, Proventa discussed the problems with rare disease clinical research. Dr. Wassmer has extensive experience in paedatric rare diseases - paediatric Multiple Sclerosis, neurometabolic and neurodegenerative...
4 years ago
Optimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries
Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...
4 years agoOptimising Screening Strategies and Early Detection of Cancer: A Challenge for Pharma and Clinical Industries
Screening methods in oncology are critical to enable doctors to detect cancer in at-risk populations. Early detection of the disease is essential to choose appropriate treatment to increase the chance of survival. The latest research identifies flaws in clinical screening...
4 years agoInterested?
Reserve your space
